The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;Haematology; change from baseline for hematology/hemostasis measures;Proportion of participants who have a post treatment seroresponse to the spike antigens of AZD1222;Biochemistry; change from baseline for blood chemistry measures;The incidence of AEs, serious adverse events (SAEs) and adverse events of special interest (AESIs)

The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;Haematology; change from baseline for hematology/hemostasis measures;Proportion of participants who have a post treatment seroresponse to the spike antigens of AZD1222;Biochemistry; change from baseline for blood chemistry measures;The incidence of AEs, serious adverse events (SAEs) and adverse events of special interest (AESIs)

The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;Proportion of participants who have a post treatment seroresponse;The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;Haematology; change from baseline for hematology/hemostasis measures;Biochemistry; change from baseline for blood chemistry measures;The incidence of AEs, serious adverse events (SAEs) and adverse events of special interest (AESIs)

The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;Proportion of participants who have a post treatment seroresponse;The incidence of local and systemic solicited reactogenicity signs and symptoms for 7 days following throughout vaccination;Haematology; change from baseline for hematology/hemostasis measures;Biochemistry; change from baseline for blood chemistry measures;The incidence of AEs, serious adverse events (SAEs) and adverse events of special interest (AESIs)